Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/33312
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMachado, Felipe V. C.-
dc.contributor.authorMeys, Roy-
dc.contributor.authorDelbressine, Jeannet M.-
dc.contributor.authorVaes, Anouk W.-
dc.contributor.authorGoërtz, Yvonne M. J.-
dc.contributor.authorVAN HERCK, Maarten-
dc.contributor.authorHouben-Wilke, Sarah-
dc.contributor.authorBoon, Gudula J. A. M.-
dc.contributor.authorBarco, Stefano-
dc.contributor.authorBURTIN, Chris-
dc.contributor.authorvan ’t Hul, Alex-
dc.contributor.authorPosthuma, Rein-
dc.contributor.authorFranssen, Frits M. E.-
dc.contributor.authorSpies, Yvonne-
dc.contributor.authorVijlbrief, Herman-
dc.contributor.authorPitta, Fabio-
dc.contributor.authorRezek, Spencer A.-
dc.contributor.authorJanssen, Daisy J. A.-
dc.contributor.authorSiegerink, Bob-
dc.contributor.authorKlok, Frederikus A.-
dc.contributor.authorSPRUIT, Martijn A.-
dc.date.accessioned2021-02-05T09:40:25Z-
dc.date.available2021-02-05T09:40:25Z-
dc.date.issued2021-
dc.date.submitted2021-02-04T11:46:10Z-
dc.identifier.citationHealth and Quality of Life Outcomes, 19 (Art N° 40)-
dc.identifier.urihttp://hdl.handle.net/1942/33312-
dc.description.abstractBackground: An increasing number of subjects are recovering from COVID-19, raising the need for tools to adequately assess the course of the disease and its impact on functional status. We aimed to assess the construct validity of the Post-COVID-19 Functional Status (PCFS) Scale among adult subjects with confirmed and presumed COVID-19. Methods: Adult subjects with confirmed and presumed COVID-19, who were members of an online panel and two Facebook groups for subjects with COVID-19 with persistent symptoms, completed an online survey after the onset of infection-related symptoms. The number and intensity of symptoms were evaluated with the Utrecht Symptom Diary, health-related quality of life (HrQoL) with the 5-level EQ-5D questionnaire, impairment in work and activities with the Work Productivity and Activity Impairment questionnaire and functional status with the PCFS Scale. Results: 1939 subjects were included in the analyses (85% women, 95% non-hospitalized during infection) about 3 months after the onset of infection-related symptoms. Subjects classified as experiencing ‘slight’, ‘moderate’ and ‘severe’ functional limitations presented a gradual increase in the number/intensity of symptoms, reduction of HrQoL and impairment in work and usual activities. No differences were found regarding the number and intensity of symptoms, HrQoL and impairment in work and usual activities between subjects classified as experiencing ‘negligible’ and ‘no’ functional limitations. We found weak-to-strong statistical associations between functional status and all domains of HrQoL (r: 0.233–0.661). Notably, the strongest association found was with the ‘usual activities’ domain of the 5-level EQ-5D questionnaire. Conclusion: We demonstrated the construct validity of the PCFS Scale in highly-symptomatic adult subjects with confirmed and presumed COVID-19, 3 months after the onset of symptoms.-
dc.description.sponsorshipThe research team acknowledges the valuable input from the patient representatives to develop the survey, and the technical support by ASolutions' Martijn Briejers and Oscar Wagemakers. We are grateful to all subjects who were willing to participate in the current study. FVCM is financially supported by ZonMW (ERACoSysMed Grant #90030355). The scientific work of YMJG is financially supported by Lung Foundation Netherlands Grant 4.1.16.085, RM is financially supported by Lung Foundation Netherlands Grant 5.1.18.232.-
dc.language.isoen-
dc.publisherSpringer Nature-
dc.rightsThe Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.-
dc.subject.otherSARS-CoV-2-
dc.subject.otherFunctional status-
dc.subject.otherSymptoms-
dc.subject.otherQuality of life-
dc.titleConstruct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19-
dc.typeJournal Contribution-
dc.identifier.issue1-
dc.identifier.volume19-
local.format.pages10-
local.bibliographicCitation.jcatA1-
local.publisher.placeCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND-
dc.relation.references1. WHO. Weekly operational update on COVID-19. https ://www.who.int/publications/m/item/weekly-epidemiological-update---12-january-2021. Accessed 17 Jan 2021. 2. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020;323(13):1239–42. 3. Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science. 2020;368(6490):489–93. 4. Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584(7820):257–61. 5. Tansey CM, Louie M, Loeb M, Muller MP, Jager J, Cameron JI, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007;167(12):1312–20. 6. Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60(5):401–9. 7. Ngai JC, Ko FW, Ng SS, To K-W, Tong M, Hui DS, et al. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3):543–50. 8. Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. The Post-COVID-19 Functional Status (PCFS) Scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56(1):2001494. 9. Klok FA, Barco S, Siegerink B. Measuring functional limitations after venous thromboembolism: a call to action. Thromb Res. 2019;178:59–62. 10. Boon GJAM, Barco S, Bertoletti L, Ghanima W, Huisman MV, Kahn SR, et al. Measuring functional limitations after venous thromboembolism: optimization of the Post-VTE Functional Status (PVFS) Scale. Thromb Res. 2020;190:45–51. 11. Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–50. 12. Public Facebook Group: Corona patiënten met langdurige klachten (Vlaanderen). 2020. https ://www.facebook.com/group s/24104 3323639334 . 13. Public Facebook Group: Corona ervaringen en langdurige klachten (Nederland). 2020. https ://www.faceb ook.com/group s/23672 3204035929 . 14. Goërtz YMJ, van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542–2020. 15. Vaes AW, Machado FVC, Meys R, Delbressine JM, Goërtz YMJ, van Herck M, et al. Care dependency in non-hospitalized patients with COVID-19. J Clin Med. 2020;9(9):2946. 16. Meys R, Delbressine JM, Goërtz YMJ, Vaes AW, Machado FVC, van Herck M, et al. Generic and respiratory—specific quality of life in non-hospitalized patients with COVID. J Clin Med. 2020;9(12):3993. 17. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737–45. 18. Hui D, Bruera E. The Edmonton symptom assessment system 25 years later: past, present, and future developments. J Pain Symptom Manag. 2017;53(3):630–43. 19. Zeng L, Zhang L, Culleton S, Jon F, Holden L, Kwong J, et al. Edmonton symptom assessment scale as a prognosticative indicator in patients with advanced cancer. J Palliat Med. 2011;14(3):337–42. 20. EuroQol Research Foundation. EQ-5D-5L User Guide, 2019. https ://euroqol.org/publications/user-guides. 21. Versteegh MM, Vermeulen KM, Evers SMAA, de Wit GA, Prenger R, Stolk EA. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19(4):343–52. 22. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–65. 23. Miller PSJ, Hill H, Andersson FL. Nocturia work productivity and activity impairment compared with other common chronic diseases. Pharmacoeconomics. 2016;34(12):1277–97. 24. Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes. 2004;2:51. 25. Fortin M, Bravo G, Hudon C, Lapointe L, Almirall J, Dubois M-F, et al. Relationship between multimorbidity and health-related quality of life of patients in primary care. Qual Life Res. 2006;15(1):83–91. 26. Bardel A, Wallander M-A, Wallman T, Rosengren A, Johansson S, Eriksson H, et al. Age and sex related self-reported symptoms in a general population across 30 years: patterns of reporting and secular trend. PLoS ONE. 2019;14(2):e0211532.-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.bibliographicCitation.artnr40-
dc.identifier.doi10.1186/s12955-021-01691-2-
dc.identifier.pmid33536042-
dc.identifier.isi000614413100001-
dc.identifier.eissn1477-7525-
local.provider.typeCrossRef-
local.uhasselt.uhpubyes-
local.dataset.citationNTR NL8705-
local.uhasselt.internationalyes-
item.fullcitationMachado, Felipe V. C.; Meys, Roy; Delbressine, Jeannet M.; Vaes, Anouk W.; Goërtz, Yvonne M. J.; VAN HERCK, Maarten; Houben-Wilke, Sarah; Boon, Gudula J. A. M.; Barco, Stefano; BURTIN, Chris; van ’t Hul, Alex; Posthuma, Rein; Franssen, Frits M. E.; Spies, Yvonne; Vijlbrief, Herman; Pitta, Fabio; Rezek, Spencer A.; Janssen, Daisy J. A.; Siegerink, Bob; Klok, Frederikus A. & SPRUIT, Martijn A. (2021) Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19. In: Health and Quality of Life Outcomes, 19 (Art N° 40).-
item.fulltextWith Fulltext-
item.validationecoom 2022-
item.contributorMachado, Felipe V. C.-
item.contributorMeys, Roy-
item.contributorDelbressine, Jeannet M.-
item.contributorVaes, Anouk W.-
item.contributorGoërtz, Yvonne M. J.-
item.contributorVAN HERCK, Maarten-
item.contributorHouben-Wilke, Sarah-
item.contributorBoon, Gudula J. A. M.-
item.contributorBarco, Stefano-
item.contributorBURTIN, Chris-
item.contributorvan ’t Hul, Alex-
item.contributorPosthuma, Rein-
item.contributorFranssen, Frits M. E.-
item.contributorSpies, Yvonne-
item.contributorVijlbrief, Herman-
item.contributorPitta, Fabio-
item.contributorRezek, Spencer A.-
item.contributorJanssen, Daisy J. A.-
item.contributorSiegerink, Bob-
item.contributorKlok, Frederikus A.-
item.contributorSPRUIT, Martijn A.-
item.accessRightsOpen Access-
crisitem.journal.eissn1477-7525-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Machado et al 2021 - Health and Quality of Life outcomes - COVID-19 and PCFS scale.pdfPublished version1.26 MBAdobe PDFView/Open
Show simple item record

WEB OF SCIENCETM
Citations

83
checked on Sep 27, 2024

Page view(s)

48
checked on Aug 20, 2022

Download(s)

52
checked on Aug 20, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.